{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:41:32Z","timestamp":1792395692427,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Prenatal genomic sequencing can detect far more than clinicians conventionally report. Whether adult-onset conditions diagnosed in the fetus should be disclosed prenatally remains debated, and most laboratories and guidelines restrict reporting to childhood-onset disease. We argue that this restriction is not supported by available evidence. Prospective parents consistently elect to receive adult-onset findings, most often to plan for a child\u2019s future health. Pediatric and newborn sequencing studies have not demonstrated the psychological, relational, or developmental harms critics anticipated, and pregnancy offers an unmatched opportunity to reach an otherwise unscreened population. Policy should be guided by informed consent and patient autonomy.<\/jats:p>","DOI":"10.1097\/grf.0000000000001056","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:02:48Z","timestamp":1789012968000},"page":"441-447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Argument in Favor of Reporting Adult-onset Conditions in Prenatal Diagnosis"],"prefix":"10.1097","volume":"69","author":[{"given":"Brittany","family":"Arditi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin D.","family":"Baptiste","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine"},{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine and Women\u2019s Genetics"},{"name":"Department of Obstetrics and Gynecology, Division of Women\u2019s Genetics, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Women\u2019s Genetics, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-1244","authenticated-orcid":false,"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Women\u2019s Genetics, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"R1-20261019","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/177330a0","article-title":"Antenatal sex determination","volume":"177","author":"Fuchs","year":"1956","journal-title":"Nature"},{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMc2300802","article-title":"Risdiplam for prenatal therapy of spinal muscular atrophy","volume":"392","author":"Finkel","year":"2025","journal-title":"N Engl J Med"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/pd.70098","article-title":"Translating emerging data for fetal treatment of cystic fibrosis","volume":"46","author":"Zaretsky","year":"2026","journal-title":"Prenat Diagn"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet Med"},{"key":"R5-20261019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"R6-20261019","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"R7-20261019","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/jmedgenet-2021-107897","article-title":"Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists","volume":"59","author":"Lazier","year":"2022","journal-title":"J Med Genet"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/pd.6157","article-title":"International Society for Prenatal Diagnosis (ISPD) Updated Position Statement from the on the use of genome-wide sequencing for prenatal diagnosis","volume":"42","author":"Van den Veyver","year":"2022","journal-title":"Prenat Diagn"},{"key":"R10-20261019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.fertnstert.2023.03.003","article-title":"Indications and management of preimplantation genetic testing for monogenic conditions: a committee opinion","volume":"120","year":"2023","journal-title":"Fertil Steril"},{"key":"R11-20261019","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pd.5973","article-title":"Preference for secondary findings in prenatal and pediatric exome sequencing","volume":"42","author":"Swanson","year":"2022","journal-title":"Prenat Diagn"},{"key":"R12-20261019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/AOG.0000000000003121","article-title":"Noninvasive prenatal whole genome sequencing: pregnant women\u2019s views and preferences","volume":"133","author":"Sullivan","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R13-20261019","doi-asserted-by":"crossref","first-page":"100002","DOI":"10.1016\/j.gim.2022.100002","article-title":"Parents\u2019 decision-making regarding whether to receive adult-onset only genetic findings for their children: findings from the BabySeq Project","volume":"25","author":"Pereira","year":"2023","journal-title":"Genet Med"},{"key":"R14-20261019","first-page":"100416","article-title":"Families\u2019 experiences of receiving adult- and pediatric-onset genetic results","volume":"6","author":"Goehringer","year":"2025","journal-title":"HGG Adv"},{"key":"R17-20261019","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/10410236.2019.1625002","article-title":"Previving: how unaffected women with a BRCA1\/2 mutation navigate previvor identity","volume":"35","author":"Getachew-Smith","year":"2020","journal-title":"Health Commun"},{"key":"R18-20261019","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10897-008-9200-1","article-title":"Life trajectories, genetic testing, and risk reduction decisions in 18\u201339 year old women at risk for hereditary breast and ovarian cancer","volume":"18","author":"Hamilton","year":"2009","journal-title":"J Genet Couns"},{"key":"R19-20261019","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ejhg.2013.143","article-title":"Experiences of predictive testing in young people at risk of Huntington\u2019s disease, familial cardiomyopathy or hereditary breast and ovarian cancer","volume":"22","author":"MacLeod","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1947603512471345","article-title":"Bioreactor-induced chondrocyte maturation is dependent on cell passage and onset of loading","volume":"4","author":"Wang","year":"2013","journal-title":"Cartilage"},{"key":"R21-20261019","doi-asserted-by":"crossref","first-page":"e003189","DOI":"10.1161\/CIRCGEN.120.003189","article-title":"The impact of genetic testing for cardiomyopathy on emotional well-being and family dynamics: a study of parents and adolescents","volume":"14","author":"Ahimaz","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamapediatrics.2021.2829","article-title":"Psychosocial effect of newborn genomic sequencing on families in the BabySeq project: a randomized clinical trial","volume":"175","author":"Pereira","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1056\/NEJMp0803964","article-title":"Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008","volume":"358","author":"Hudson","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","year":"2020","journal-title":"Genet Med"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s10038-025-01349-7","article-title":"ACMG secondary findings in the Brazilian rare genomes project: insights from 5402 genome sequencing","volume":"70","author":"Perrone","year":"2025","journal-title":"J Hum Genet"},{"key":"R26-20261019","doi-asserted-by":"crossref","first-page":"101225","DOI":"10.1016\/j.gim.2024.101225","article-title":"Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants","volume":"26","author":"Saeidian","year":"2024","journal-title":"Genet Med"},{"key":"R27-20261019","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1002\/cncr.35480","article-title":"Considering screening for hereditary cancer syndromes at the time of obstetrical prenatal carrier screening","volume":"130","author":"Perez","year":"2024","journal-title":"Cancer"},{"key":"R28-20261019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ypmed.2019.02.027","article-title":"Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: results from the 2015 National Health Interview Survey","volume":"123","author":"Turbitt","year":"2019","journal-title":"Prev Med"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National estimates of genetic testing in women with a history of breast or ovarian cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J Clin Oncol"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.ajog.2024.04.014","article-title":"Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention","volume":"231","author":"Dioun","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R32-20261019","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41436-018-0277-0","article-title":"Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility","volume":"21","author":"Rowley","year":"2019","journal-title":"Genet Med"},{"key":"R33-20261019","doi-asserted-by":"crossref","first-page":"e250917","DOI":"10.1001\/jamanetworkopen.2025.0917","article-title":"Genomic screening at a single health system","volume":"8","author":"Savatt","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R34-20261019","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41436-018-0367-z","article-title":"27 years of prenatal diagnosis for Huntington disease in the United Kingdom","volume":"21","author":"Pi\u00f1a-Aguilar","year":"2019","journal-title":"Genet Med"},{"key":"R35-20261019","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/MS9.0000000000004574","article-title":"AMT-130 gene therapy: a promising disease-modifying approach for Huntington\u2019s disease","volume":"88","author":"Mwape","year":"2026","journal-title":"Ann Med Surg (Lond)"},{"key":"R36-20261019","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41436-020-0900-8","article-title":"Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time","volume":"22","author":"van Rooij","year":"2020","journal-title":"Genet Med"},{"key":"R38-20261019","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/AOG.0000000000005804","article-title":"Increasing Access to Abortion: ACOG Committee Statement No. 16","volume":"145","author":"Reisinger-Kindle","year":"2025","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GRF.0000000000001056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:26Z","timestamp":1792393226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/GRF.0000000000001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000001056","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"2026-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}